Capital increase in Aquaporin A/S as result of exercise of warrants
Company announcement no. 20/2021
Aquaporin A/S (the “Company”) has increased in its share capital by 51,500 shares of nominal value of DKK 1 each as a consequence of the exercise of 51,500 warrants by certain current and former employees of the company.
The capital increase is effected without any pre-emptive rights for the existing shareholders of the Company.
The shares have been subscribed for in cash at the following exercise price per share of nominally DKK 1 in connection with the exercise of warrants in accordance with the terms set out in the relevant warrant programs: 38,500 shares at a price of DKK 119.86 and 13,000 shares at a price of DKK 20. The aggregate subscription price received by the Company is DKK 4,874,610.
The new shares are ordinary shares and will rank pari passu in all respects with the existing Aquaporin shares. The new shares are expected to be admitted to trading and official listing on Nasdaq Copenhagen on 15 September 2021 under the Company’s permanent ISIN DK0061555109 and the symbol “AQP”.
Following the capital increase and in accordance with the disclosure requirements in section 32 of the Danish Capital Markets Act, the share capital of Aquaporin consists of DKK 10,130,801 shares of a nominal value of DKK 1 each. Each share of DKK 1 carries one vote at Aquaporin’s general meetings and accordingly the number of voting rights in Aquaporin are DKK 10,130,801.
As a result of the exercise of warrants and the lapse of any remaining warrants outstanding under the programs issued under items 4.9.b, 4.10.a and 4.12.a of the Articles of Association of Company, the number of outstanding warrants in Aquaporin A/S is 156,893 corresponding to 1.56% of the current share capital.
Below is an overview of the outstanding warrants:
| Program | Number of warrants outstanding | Exercise price | Exercise period |
| 4.11 | 55,484 | DKK 30.00 | 19/12/2014 - 19/12/2021 |
| 4.14.a | 10,000 | DKK 119.86 | 28/02/2018 - 27/02/2023 |
| 4.14.b | 30,000 | DKK 157.84 | 05/07/2019 - 01/07/2024 |
| 4.15.a | 61,409 | DKK 173.00 | 05/07/2024 - 05/07/2026 |
The updated Articles of Association have been registered with the Danish Business Authority today and can be found at www.aquaporin.com.
For additional information, please contact:
Aquaporin
Niels Heering, Chairman
Peter Holme Jensen, CEO
Mikkel Tanderup, Head of Investor Relations
Contact information: +45 53 55 55 05, investorrelations@aquaporin.com
About Aquaporin
The Company is a water technology company headquartered in Denmark with operations in Denmark, Singapore and the United States. The aim of the Company’s technology is to contribute to a more sustainable world by focusing on encouraging responsible consumption of water. As a result, the Company is committed to developing and providing cost-efficient, sustainable and environmentally responsible solutions to the growing need for access to clean drinking water, treating and reusing wastewater and improving concentration and separation performance. For this purpose, the Company has developed a proprietary and patent-protected formulation for the protein aquaporin, which enables a high rejection rate of pollutants, high recovery rate of clean water and low energy consumption. The Company’s proprietary technology, Aquaporin Inside®, is based on Nobel Prize-winning research and used to clean and reuse water in our homes and in the industrial water and food and beverage industry. Aquaporin works with customers and partners around the globe to sustainably treat industrial wastewater, concentrate food and beverage products and enhance drinking water quality and accessibility. Read more on www.aquaporin.com
